Human papillomavirus DNA in pharyngeal scrapes as a marker of HPV-related squamous cell cancer of the oropharynx

Journal of Clinical Virology

Volumn 71, Issue , 2015, Pages 34-39

  Snietura, Miroslaw ^a   Rutkowski, Tomasz ^a   Piglowski, Wojciech ^a   Hajduk, Agata ^a   Wygoda, Andrzej ^a   Skladowski, Krzysztof ^a   Lange, Dariusz ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Head and neck squamous cell cancer; Human papillomavirus; Oropharyngeal cancer; Oropharynx; P16(INK4A); Pharyngeal scraps; RT PCR

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER RECURRENCE; CANCER TISSUE; CYTOLOGY; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HAZARD RATIO; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THROAT CULTURE; WART VIRUS; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; OROPHARYNX; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHARYNGEAL NEOPLASMS; PROCEDURES; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; OROPHARYNX; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHARYNGEAL NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 84941584465     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.07.307     Document Type: Article

References (30)

1. Schwartz S.M., Daling J.R., Doody D.R., Wipf G.C., Carter J.J., Madeleine M.M., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. 1998, 90:1626-1636.
2. Herrero R., Castellsagué X., Pawlita M., Lissowska J., Kee F., Balaram P., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 2003, 95:1772-1783.
3. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 2008, 26:612-619. 10.1200/JCO.2007.14.1713.
4. Gillison M.L. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J. Adolesc. Health 2008, 43:S52-S60. 10.1016/j.jadohealth.2008.07.002.
5. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 2008, 100:261-269. 10.1093/jnci/djn011.
6. Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J., et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother. Oncol. J. 2010, 94:30-35. 10.1016/j.radonc.2009.10.008.
7. Snietura M., Piglowski W., Jaworska M., Mucha-Malecka A., Wozniak G., Lange D., et al. Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer. Eur. Arch. Oto-Rhino-Laryngol. 2011, 268:721-726. 10.1007/s00405-010-1396-7.
8. Śnietura M., Jaworska M., Pigłowski W., Goraj-Zajac A., Woźniak G., Lange D. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx. Pol. J. Pathol. 2010, 61:133-139.
9. Altman D.G., McShane L.M., Sauerbrei W., Taube S.E. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med. 2012, 9:e1001216. 10.1371/journal.pmed.1001216.
10. Huang S., Erickson B., Tang N., Mak W.-B., Salituro J., Robinson J., et al. Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology. J. Clin. Virol. 2009, 45(Suppl. 1):S19-S23. 10.1016/S1386-6532(09)70004-6.
11. Kocjan B.J., Maver P.J., Hosnjak L., Zidar N., Odar K., Gale N., et al. Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancer. Acta Dermatovenerol. Alp. Pannonica Adriat. 2012, 21:73-75.
12. Huang S., Tang N., Mak W.-B., Erickson B., Salituro J., Li Y., et al. Principles and analytical performance of Abbott RealTime High Risk HPV test. J. Clin. Virol. 2009, 45(Suppl. 1):S13-S17. 10.1016/S1386-6532(09)70003-4.
13. Quint W.G., Scholte G., van Doorn L.J., Kleter B., Smits P.H., Lindeman J. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping. J. Pathol. 2001, 194:51-58. 10.1002/path.855.
14. Syrjänen K., Syrjänen S. Concept of the existence of human papillomavirus (HPV) DNA in histologically normal squamous epithelium of the genital tract should be re-evaluated. Acta Obstet. Gynecol. Scand. 1989, 68:613-617.
15. Furrer V.E., Benitez M.B., Furnes M., Lanfranchi H.E., Modesti N.M. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J. Oral Pathol. Med. 2006, 35:338-344. 10.1111/j.1600-0714.2006.00423.x.
16. Maden C., Beckmann A.M., Thomas D.B., McKnight B., Sherman K.J., Ashley R.L., et al. Human papillomaviruses herpes simplex viruses, and the risk of oral cancer in men. Am. J. Epidemiol. 1992, 135:1093-1102.
17. Smith E.M., Swarnavel S., Ritchie J.M., Wang D., Haugen T.H., Turek L.P. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr. Infect. Dis. J. 2007, 26:836-840. 10.1097/INF.0b013e318124a4ae.
18. D'souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007, 356:1944-1956. 10.1056/NEJMoa065497.
19. Mendelsohn A.H., Lai C.K., Shintaku I.P., Elashoff D.A., Dubinett S.M., Abemayor E., et al. Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010, 120:1788-1794. 10.1002/lary.21044.
20. Robinson M., Sloan P., Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol. 2010, 46:492-496. 10.1016/j.oraloncology.2010.02.013.
21. Lewis J.S., Thorstad W.L., Chernock R.D., Haughey B.H., Yip J.H., Zhang Q., et al. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am. J. Surg. Pathol. 2010, 34:1088-1096. 10.1097/PAS.0b013e3181e84652.
22. Chai R.C., Lambie D., Verma M., Punyadeera C. Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer Med. 2015, 10.1002/cam4.424.
23. Deng Z., Hasegawa M., Aoki K., Matayoshi S., Kiyuna A., Yamashita Y., et al. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma. Int. J. Oncol. 2014, 45:67-76. 10.3892/ijo.2014.2440.
24. Smith E.M., Hoffman H.T., Summersgill K.S., Kirchner H.L., Turek L.P., Haugen T.H. Human papillomavirus and risk of oral cancer. Laryngoscope 1998, 108:1098-1103.
25. Smith E.M., Ritchie J.M., Summersgill K.F., Hoffman H.T., Wang D.H., Haugen T.H., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J. Natl. Cancer Inst. 2004, 96:449-455.
26. Lawton G., Thomas S., Schonrock J., Monsour F., Frazer I. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J. Oral Pathol. Med. 1992, 21:265-269.
27. Bussu F., Sali M., Gallus R., Vellone V.G., Zannoni G.F., Autorino R., et al. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker. Br. J. Cancer 2013, 108:1157-1162. 10.1038/bjc.2013.55.
28. Licitra L., Perrone F., Bossi P., Suardi S., Mariani L., Artusi R., et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 2006, 24:5630-5636. 10.1200/JCO.2005.04.6136.
29. Rittà M., De Andrea M., Mondini M., Mazibrada J., Giordano C., Pecorari G., et al. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 2009, 31:318-327. 10.1002/hed.20977.
30. O'Rorke M.A., Ellison M.V., Murray L.J., Moran M., James J., Anderson L.A. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012, 48:1191-1201. 10.1016/j.oraloncology.2012.06.019.